Spironolactone and ACE inhibition in chronic renal failure.
Almirall
Jaume
J
Lopez
Thaïs
T
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D048909:Diabetes Complications; D004359:Drug Therapy, Combination; D006801:Humans; D006947:Hyperkalemia / Q000209:etiology*; D007676:Kidney Failure, Chronic / Q000150:complications / Q000188:drug therapy*; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*; D011507:Proteinuria / Q000188:drug therapy; D013148:Spironolactone / Q000627:therapeutic use*
D000806:Angiotensin-Converting Enzyme Inhibitors; D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone